CBTi for the Treatment of Insomnia in Type 1 Diabetes

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jul 21, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether a special type of therapy called Cognitive Behavioral Therapy for Insomnia (CBTi) can help people with Type 1 diabetes who have trouble sleeping. The researchers want to see if improving sleep can also help control blood sugar levels and improve overall quality of life, including mood and energy. To find out, they will compare people who receive the sleep therapy with those who get general health education and support.

Adults between 18 and 65 years old who have had Type 1 diabetes for at least a year, use a continuous glucose monitor (a device that tracks blood sugar levels), and have poor sleep quality may be eligible to join. Participants in the therapy group will meet with a therapist online for eight sessions over 12 weeks, while those in the health education group will get weekly emails and short phone calls. Everyone will wear a sleep-tracking watch for two weeks, share their sugar level data, answer questionnaires, and attend three office visits during the study. This trial is not yet recruiting, and certain people, such as those who are pregnant, working night shifts, or have serious health issues, will not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Between 18 to 65 years old
• • Have been diagnosed with Type 1 Diabetes for at least a year
• • Use a continuous glucose monitor
• • Have poor sleep quality
• • Able to attend 3 office visits
• Exclusion Criteria:
• • Currently or planning pregnancy or breast feeding
• • Employed with a rotating or night shift
• • Are at a high risk for obstructive sleep apnea
• • Non-English speaking (unable to participate in therapy or questionnaire).
• • Take medications for sleep
• • moderately severe to severe depression
• • Have a significant medical history that includes conditions like heart failure, cirrhosis, COPD, diseases requiring oxygen, active treatment for cancer or psychiatric problems, history of stroke with neurological deficits, cognitive impairment, kidney failure that requires dialysis, illicit drug use, use of ADHD stimulant medications.